David Thomson
Corporate Officer/Principal en North Carolina Central University .
Perfil
David Thomson is currently a Professor of Pharmaceutical Sciences at North Carolina Central University and a Vice President at Shire Human Genetic Therapies, Inc. He was previously the Chief Operating Officer at Precision BioSciences, Inc. from 2019 to 2021.
Thomson holds a doctorate degree from Yale University and the University of Toronto, and an undergraduate degree from the University of Strathclyde.
Cargos activos de David Thomson
Empresas | Cargo | Inicio |
---|---|---|
North Carolina Central University | Corporate Officer/Principal | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de David Thomson.
Empresas | Cargo | Fin |
---|---|---|
PRECISION BIOSCIENCES, INC. | Chief Operating Officer | 02/07/2021 |
Formación de David Thomson.
Yale University | Doctorate Degree |
University of Toronto | Doctorate Degree |
University of Strathclyde | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PRECISION BIOSCIENCES, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
- Bolsa de valores
- Insiders
- David Thomson